Indeed, these three checkpoint molecules are upregulated upon T-cell activation during the anti-tumor response, and tumor-infiltrating CTLA-4 + PD-1 + CD8 + T cells have been shown to contain the majority of tumor-antigen-specific T cells21,22. This evidence concerns the gene CTLA4 and neoplasm.